Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education
This is an independent editorial review. PlexusDx has no commercial relationship with Direct Meds or its parent company. No affiliate links or compensation are involved.
This review evaluates Direct Meds specifically as a medical weight-loss program — its model, who qualifies, the medications involved, and what it costs. It is fair-balance editorial context to help you assess fit, not a buying recommendation. As of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Direct Meds as a weight-loss program
Direct Meds delivers medical weight loss through telehealth paired with a compounded pharmacy. The structure is remote clinical care: a licensed provider evaluates you virtually, writes a prescription, and the medication is dispensed either by a retail pharmacy for an FDA-approved brand product or by a 503A compounding pharmacy for compounded semaglutide or tirzepatide, with ongoing follow-up. Program details appear on the brand’s own website (search for the current URL at the time of reading).
Who qualifies: the eligibility and intake step
Eligibility is decided clinically, not automatically. You start with an intake form covering weight, medical history, and current medications; a licensed clinician reviews it and issues a prescription only if you meet the program’s criteria; the prescription routes to a retail or licensed compounding pharmacy; and follow-up visits support dose titration and side-effect management. Provider type, pharmacy partner, and subscription structure vary between programs.
The medications behind medical weight loss
Medical weight-loss programs prescribe from a defined compound class: GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide). Whether you receive a branded or compounded version depends on the prescription and the program’s pharmacy pathway. The specific medication and form are set by the clinician rather than chosen from a menu.
What weight-loss trials show
The evidence base for these compounds includes STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Trial populations and endpoints vary, and individual outcomes differ.
What the program costs
Direct Meds publishes pricing on its own website, with totals varying by product, subscription tier, and branded-versus-compounded dispensing. Telehealth GLP-1 programs as of April 2026 typically run between roughly $200 and $700+ per month, with wide variance — verify the live figure before committing.
The missing input: your weight-regulation genetics
A weight-loss program prescribes a compound but does not map the genetic architecture that shapes how your body regulates weight. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene and target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor linked to glucose homeostasis) describe your baseline terrain. These pathway-level markers do not predict response to any compound, but they add context a prescription alone omits.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols — available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 — the test before you invest foundation for an informed weight-management decision.
Not affiliated: PlexusDx is not affiliated with Direct Meds and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: GLP 1 For Weight Loss, Wegovy For Weight Loss.
Disclaimer: This article is educational. PlexusDx is not affiliated with Direct Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols — this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the PlexusDx approach: see the Weight Management Protocols — semaglutide and tirzepatide with the genetic context most telehealth programs don’t offer. Or start upstream: take the Precision Peptide Genetic Test first.
Frequently Asked Questions
How does the Direct Meds weight-loss program work?
It combines telehealth with a compounded pharmacy: a licensed provider evaluates your intake, issues a prescription if eligibility is met, a retail or 503A pharmacy fills it, and follow-up supports dose titration. Specifics, including eligibility and pricing, appear on the brand’s own website.
Who is eligible for GLP-1 weight-loss telehealth?
Eligibility is determined by a licensed clinician who reviews your weight, medical history, and current medications against the program’s criteria. There is no universal rule; the prescriber decides case by case, and any contraindications or requirements are documented on Direct Meds’s own site, which is where you should confirm the current details.
Can a genetic test guide weight-loss decisions?
The Precision Peptide Genetic Test does not predict response to any program or compound. It analyzes pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline weight-regulation biology — upstream context to bring to a conversation with your provider.
How does PlexusDx approach weight management?
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, paired with the Precision Peptide Genetic Test for genetic context that most telehealth-only programs do not include alongside the medication. The focus is informed, individualized decisions guided by your baseline weight-regulation biology and your provider.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Direct Meds Legit? Credentialing, Compounding, Oversight
Direct Meds GLP-1 Program: How It Works and What It Offers